Conference Proceeding

How Missing a Treatment of Mixed Amphetamine Salts Extended Release Affects Performance in Teen Drivers with ADHD

Authors
  • Lana M Trick (University of Guelph, Guelph, Ontario, Canada)
  • Ryan Toxopeus (University of Guelph, Guelph, Ontario, Canada)

Abstract

Mixed Amphetamine Salts Extended Release (MAS-XR or Adderall XR®) is a stimulant medication used to control symptoms of ADHD. People occasionally fail to take their medications. The goal of this pilot study was to assess the impact of a single missed medication on driving performance in 14 teen drivers with ADHD mixed type as a function of driving skill. A double-blind placebo control crossover design was used and participants were tested in a driving simulator. On the evening of the first day, baseline measures of driving performance were taken to assess driving skills (on medication). Then on two consecutive days drivers were tested three times a day, one day on medication and the other day off. Results indicated increased collisions and hazard response time off medication, with performance worst on 36 hours post-medication. Participants with the least developed driving skills benefited most from medication. This highlights the importance of consistent medication use in inexperienced teen drivers with ADHD.

How to Cite:

Trick, L. & Toxopeus, R., (2013) “How Missing a Treatment of Mixed Amphetamine Salts Extended Release Affects Performance in Teen Drivers with ADHD”, Driving Assessment Conference 7(2013), 99-105. doi: https://doi.org/10.17077/drivingassessment.1473

Rights: Copyright © 2013 the author(s)

Downloads:
Download pdf
View PDF

70 Views

120 Downloads

Published on
18 Jun 2013
Peer Reviewed